Exome sequencing: Potential diagnostic assay for unexplained intellectual disability

Public release date: 8-Nov-2012 [ | E-mail | Share ]

Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics

Research findings confirming that de novo mutations represent a major cause of previously unexplained intellectual disability were presented on Nov. 8 at the American Society of Human Genetics 2012 meeting in San Francisco.

Josep de Ligt, M.Sc., bioinformatician and Ph.D. student in human genetics at Radboud University Nijmegen Medical Centre in The Netherlands, also reported findings lending support to the use of exome sequencing, which deciphers over 21,000 protein-coding genes and not the entire human genome, as a diagnostic assay to determine whether one or more genetic mutations explain a patient's intellectual disability.

The cause of intellectual disability, which represents a wide range of phenotypes, or observable biological characteristics, is unknown in at least 50% of patients.

Most individuals with intellectual disability without a known cause are the only members of their families with the condition. Because the cause of their child's cognitive impairment is unknown, parents are often baffled.

The child with a cognitive disability is often an "isolated case without family history of the condition," said de Ligt, adding that intellectual disability occurs in about 1% of the population,

By exome sequencing of 100 patients with unexplained cognitive impairment, de Ligt and his colleagues uncovered 79 genes with unique de novo mutations.

These de novo mutations were present in the DNA of the patients but not in that of their parents whose exomes also were sequenced.

"All de novo as well as X-linked mutations identified in this study were interpreted in the context of the clinical diagnosis," de Ligt pointed out.

Here is the original post:
Exome sequencing: Potential diagnostic assay for unexplained intellectual disability